|
Volumn 32, Issue 7, 2014, Pages 653-655
|
Backbone modification of a polypeptide drug alters duration of action in vivo
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOTECHNOLOGY;
ACID RESIDUES;
G PROTEIN COUPLED RECEPTORS;
HIGH ACTIVITY;
IN-VIVO;
PARATHYROID HORMONE RECEPTORS;
PHARMACOKINETIC PROPERTIES;
POLYPEPTIDES;
ADENYLATE CYCLASE;
ALPHA AMINO ACID;
BETA AMINO ACID;
CALCIUM ION;
G PROTEIN COUPLED RECEPTOR;
HYBRID PROTEIN;
IMMUNOGLOBULIN G;
MOLECULAR SCAFFOLD;
PARATHYROID HORMONE[1-34];
AMINO TERMINAL SEQUENCE;
ANIMAL EXPERIMENT;
ARTICLE;
CARBOXY TERMINAL SEQUENCE;
CHEMICAL MODIFICATION;
DRUG POTENCY;
ENZYME CONFORMATION;
HORMONE ACTION;
HUMAN;
IN VITRO STUDY;
IN VIVO STUDY;
MOUSE;
NONHUMAN;
PHYSIOLOGICAL PROCESS;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
PROTEIN MODIFICATION;
RAT;
RECEPTOR AFFINITY;
RECEPTOR BINDING;
SIGNAL TRANSDUCTION;
SOLID PHASE SYNTHESIS;
WASTE;
AMINO ACID SUBSTITUTION;
AMINO ACIDS;
ANIMALS;
MALE;
METABOLIC CLEARANCE RATE;
MICE, INBRED C57BL;
PEPTIDE HORMONES;
RECEPTOR, PARATHYROID HORMONE, TYPE 1;
STRUCTURE-ACTIVITY RELATIONSHIP;
TISSUE DISTRIBUTION;
|
EID: 84903964236
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt.2920 Document Type: Article |
Times cited : (99)
|
References (20)
|